CLINICAL_TRIALS
trial_result
· 2015-11-10
Clinical Trial Update: R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma [Phase 2]
Summary
Phase 2 study evaluating the R-MACLO-IVAM regimen with thalidomide in untreated mantle cell lymphoma; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Miami | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2015-11-10